TLP Group’s West Pharmaceutical WST Stock Holding History

TLP Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,897	Closed	-$187K	–	647
2017 Q4	$187K	Buy	+1,897	New	+$186K	0.13%	156

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

TLP Group's WST Position: Q1 2018 in Review

TLP Group sold out of West Pharmaceutical (WST) in Q1 2018, closing a stake of 1,897 shares — an estimated $187K sold.

TLP Group first reported a position in WST in Q4 2017 and held it in 1 quarter. The position peaked at $187K in Q4 2017. 323 funds tracked by Wall St. Rank hold WST as of Q1 2018.

TLP Group reported no remaining West Pharmaceutical position as of Q1 2018 after selling out during the quarter.
TLP Group sold 1,897 West Pharmaceutical shares in Q1 2018, an estimated $187K.
TLP Group first reported a position in West Pharmaceutical in Q4 2017 and held it in 1 quarter.
TLP Group's West Pharmaceutical position peaked at $187K in Q4 2017.
323 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2018.

Based on TLP Group's 13F filing for Q1 2018, filed 16 May 2018.